Sightera
Antwerp, BE · 1 known investors
Find your way into Sightera
Sign up to see every warm intro you have to Sightera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sightera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sightera Biosciences is an AI-native biotech that generates proprietary response data from treatment-resistant, end-stage patient tissue and organoid models, then uses generative AI to design first-in-class small molecules. It is building a pipeline of small molecule, molecular glue and payload assets across cancers (pancreatic, biliary tract, colorectal, gastric, esophageal, and other solid tumors) and fibrotic diseases.
Investors · 1
Frequently asked questions
- What does Sightera do?
- Sightera Biosciences is an AI-native biotech that generates proprietary response data from treatment-resistant, end-stage patient tissue and organoid models, then uses generative AI to design first-in-class small molecules. It is building a pipeline of small molecule, molecular glue and payload assets across cancers (pancreatic, biliary tract, colorectal, gastric, esophageal, and other solid tumors) and fibrotic diseases.
- Who are Sightera's investors?
- Sightera's investors include Entourage Ventures.
- Where is Sightera headquartered?
- Sightera is headquartered in Antwerp, BE.
